13F HOLDINGS REPORT
Propel Bio Management, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001829126-25-000973
Total Value
$100.7M
Positions
21
Other Managers
1
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PLAINS GP HOLDINGS LP-CL | PAGP | 1,272,360 | $23.4M | 23.23% |
| 2 | MADRIGAL PHARMACEUTICALS | MDGL | 43,032 | $13.3M | 13.19% |
| 3 | AKERO THERAPEUTICS INC | 00973Y108 | 343,729 | $9.6M | 9.50% |
| 4 | ACHIEVE LIFE SCIENCES INC | ACHV | 2,453,092 | $8.6M | 8.58% |
| 5 | APPLIED THERAPEUTICS INC | 03828A101 | 9,615,420 | $8.2M | 8.18% |
| 6 | PHATHOM PHARMACEUTICALS I | PHAT | 989,927 | $8.0M | 7.98% |
| 7 | TSCAN THERAPEUTICS INC | TCRX | 2,087,139 | $6.3M | 6.30% |
| 8 | AVIDITY BIOSCIENCES INC | 05370A108 | 178,500 | $5.2M | 5.16% |
| 9 | ARDELYX INC | ARDX | 950,947 | $4.8M | 4.79% |
| 10 | ABEONA THERAPEUTICS INC | ABEO | 624,022 | $3.5M | 3.45% |
| 11 | SYNDAX PHARMACEUTICALS IN | SNDX | 183,259 | $2.4M | 2.41% |
| 12 | KYMERA THERAPEUTICS INC | KYMR | 56,359 | $2.3M | 2.25% |
| 13 | ZEVRA THERAPEUTICS INC | ZVRA | 179,874 | $1.5M | 1.49% |
| 14 | KURA ONCOLOGY INC | KURA | 130,000 | $1.1M | 1.12% |
| 15 | ATHIRA PHARMA INC | 04746L104 | 1,492,792 | $875,821 | 0.87% |
| 16 | EIGER BIOPHARMACEUTICALS | 28249U204 | 146,381 | $765,000 | 0.76% |
| 17 | JASPER THERAPEUTICS INC | JSPRW | 20,000 | $427,600 | 0.42% |
| 18 | DELCATH SYSTEMS INC | DCTH | 17,000 | $204,680 | 0.20% |
| 19 | COMPASS PATHWAYS PLC | CMPS | 25,209 | $95,290 | 0.09% |
| 20 | MAAT PHARMA SACA | F5888J116 | 3,151 | $25,082 | 0.02% |
| 21 | CHINOOK THERAPEUTICS | 169CVR016 | 79,357 | $9,750 | 0.01% |